Exposure and risk assessment with respect to contaminated soil: Significance of biomarkers and bioavailability

International Journal of Toxicology

Volumn 16, Issue 4-5, 1997, Pages 419-432

  Rangan, Urvashi ^a   Hedli, Christine ^a   Gallo, Michael ^a   Lioy, Paul ^a   Snyder, Robert ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b 414 EOHSI ^*  (United States)

Author keywords

Benzene; Bioavailability; Biomarkers; Risk assessment; TCDD

Indexed keywords

BIOCHEMICAL MARKER;

BIOAVAILABILITY; CHROMOSOME DAMAGE; CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; GENETIC SUSCEPTIBILITY; HEALTH HAZARD; PARTICULATE MATTER; PREDICTION; RISK ASSESSMENT; SOIL POLLUTION;

ANIMALIA;

EID: 0030763870     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158197227044     Document Type: Conference Paper

References (36)

1. Bailer, A. L., and Hoel, D. G. 1989. Metabolite-based internal doses used in risk assessment of benzene. Environ. Health Perspect. 82:177.
2. Bechtold, W. E., and Henderson, R. F. 1993. Biomarkers of human exposure to benzene. J. Toxicol. Environ. Health 40:377.
3. Bodell, W. J., Levay, G., and Pongracz, K. 1993. Investigation of benzene-DNA adducts in their detections in human bone marrow. Environ. Health Perspect. 99:241.
4. Ekblom, M., Von Willebrand, E., and Gahmberg, C. G., Borgström, G., Vuopio, P., and Anderson, L. C. 1983. Erythroid blast crisis in chronic myelogenous leukemia. Blood 62:591.
5. Georgopoulos, P., and Lioy, P. J. 1994. Conceptual and theoretical aspects of exposure and dose assessment. J. Exp. Anal. Environ. Epidemiol. 4:253.
6. Golomb, H. M., Alimena, G., Rowley, J. D., Vardiman, J. W., Testa, J. R., and Sovik, C. 1982. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 60:404.
7. Hagmar, L., Brogger, A., Hansteen, I. L., Heim, S., Hogstedt, B., Knudsen, L., Lambert, B., Linnainmaa, K., Mitelman, F., and Nordenson, I. 1994. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 54:2919.
8. Hedli, C. C., Rao, N. R., Reuhl, K. R., Witmer, C. M., and Snyder, R. 1996. Effects of benzene metabolite treatment on granulocyte differentiation and DNA adduct formation in HL 60 cells. Arch. Toxicol. 70:135.
9. Henderson, R. F., Sabourin, P. J., Bechtold, W. E., Griffith, W. C., Medinsky, M. A., Birnbaum, L. S., and Lucler, G. W. 1989. The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ. Health Perspect. 82:9.
10. Kociba, R. J. 1987. Animal toxicity studies of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. In Solving Hazardous Waste Problems: Learning from Dioxins, ed. J. H. Exner. Washington, DC.: American Chemical Society.
11. Krishnan, K., and Pelekis, M. 1995. Hematotoxic interactions: occurrence, mechanisms, and predictability. Toxicology 105:355.
12. Layard, M. W., and Silvers, A. 1989. Epidemiology in environmental risk assessment. In The risk assessment of environmental hazards, ed. D. Paustenbach. New York: John Wiley and Sons.
13. LeBeau, M. M., and Larson, R. A. 1991. Cytogenetics and neoplasia. In Hematology, pp. 638-656. New York: Churchill Livingstone.
14. Lioy, P. J. 1990. Assessing total human exposure to contaminants. Environ. Sci. Technol. 24:938.
15. Lioy, P. J. 1995. Measurement methods for human exposure analysis. Environ. Health Perspect. 103(suppl 3):35.
16. Liszka, K., Majdic, O., Betteleim, P., and Knapp, W. 1983. Glycophorin A expression in malignant hematopoiesis. Am. J. Hematol. 15:219.
17. Mendelsohn, M. L. 1995. Biomarkers and occupational health: progress and perspectives, ed. M. L. Mendelsohn, J. P. Peeters, and M. J. Normandy. Washington, DC: Joseph Henry Press.
18. Musilova, J., Michalova, K., Zemanova, Z., Neuwirthova, R., and Dohnalova, A. 1995. Karyotype at diagnosis, subsequent leukemic transformation and survival in myelodysplastic syndrome. Leuk. Res. 19:303.
19. National Research Council. 1988. Methods for In Vivo Toxicity Testing. In Complex Mixtures. Washington, DC: National Academy of Sciences Press.
20. Ong, C. N., Kok, P. W., Lee, B. L., Shi, C. Y., Ong, H. Y., Chia, K. S., Lee, C. S., and Luo, K. W. 1995. Evaluation of biomarkers for occupational exposure to benzene. Occup. Environ. Med. 52:528.
21. Paquette, R. L., Landaw, E. M., Pierre, R. V., Kahan, J., Lubbert, M., Lazcano, O., Isaac, G., McCormack, F., and Koeffler, H. P. 1993. N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodys-plastic syndrome. Blood 82:590.
22. Pathak, D. N., Levay, G., and Bodell, W. J. 1995. DNA adduct formation in bone marrow of B6C3F1 mice treated with benzene. Carcinogenesis 16:1803.
23. Paustenbach, D. J., Bass, R. D., and Price, P. 1993. Benzene toxicity and risk assessment, 1972-1992: implications for future regulations. Environ. Health Perspect. 101(suppl 6):177.
24. Peakill, D. B. 1993. Biomarkers: Research application in the assessment of environmental health. ed. D. B. Peakill, and L. R. Shugart. New York: Springer-Verlag.
25. Popp, W., Vahrenholz, C., Yaman, S., Müller, C., Müller, G., Schmieding, W., Norpoth, K., and Fahnert, R. 1992. Investigations of the frequency of DNA strand breakage and cross-linking and of sister chromatid exchange frequency in the lymphocytes of female workers exposed to benzene and toluene. Carcinogenesis 13:57.
26. Rideout, V. C. 1991. A first course in computer-aided physiological modeling. Biomed. Sci. Instrument. 27:89.
27. Rothman, N., Haas, R., Hayes, R. B., Li, G. L., Wiemels, J., Campleman, S., Quintana, P. J., Xi, L. J., Dosemici, M., Titenko-Holland, N., Meyer, K. B., Lu, W., Zhang, L. P., Bechtold, W., Wang, Y. Z., Kolachana, P., Yin, S. N., Blot, W., and Smith, M. T. 1995. Benzene induces gene-duplicating but not gene-in activating mutations at the glycophorin A locus in exposed humans. Proc. Natl. Acad. Sci. U.S.A. 92:4069.
28. Sasiadek, M. 1992. Nonrandom distribution of breakpoints in the karyotype of workers occupationally exposed to benzene. Environ. Health Perspect. 97:255.
29. Schulte, P., and Mazzuckelli, L. F. 1991. Validation of biological markers for quantitative risk assessment. Environ. Health Perspect. 90:239.
30. Snyder, R., and Kalf, G. F. 1994. A perspective on benzene leukemogenesis. Crit. Rev. Tox. 24:177.
31. Tompa, A., Major, J., and Jakab, M. G. 1994. Monitoring benzene-exposed workers for genotoxic effects of benzene: improved-working-condition-related decrease in the frequencies of chromosomal aberrations in peripheral blood lymphocytes. Mut. Res. 304:159.
32. Umbreit, T. H., Hesse, E. J., and Gallo, M. A. 1986. Bioavailability of dioxin in soil from a 2, 4, 5-T manufacturing site. Science 232:497.
33. Umbreit, T. H., Hesse, E. J., and Gallo, M. A. 1988. Bioavailability and cytochrome P-450 induction from 2, 3, 7, 8-tetrachlorodibenzo-P-dioxin contaminated soils from Times Beach, Missouri, and Newark, New Jersey. Drug Chem. Toxicol. 11:405.
34. Umbreit, T. H., Engles, D., Grossman, A., and Gallo, M. A. 1989. Species comparison of steroid UDP-glucuronyl transferase: correlation to TCDD sensitivity. Toxicol. Lett. 48:29.
35. Wallace, L. A. 1989. Major sources of benzene exposure. Environ. Health Perspect. 82:165.
36. Yager, J. W., Eastmond, D. A., and Robertson, M. L. 1990. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res. 20:393.